-
-
Despite the relatively frequent and probably increasing prevalence of recurrent bacterial skin infections, particularly furunculosis and cellulitis, there are few established evidence-based guidelines for their therapy and prevention. This review provides a pathophysiological approach to diagnosis, therapy, and prevention of these infections for the practicing physician and his or her patients.
-
Counterfeit Procrit Uncovered by FDA Surveillance; Pharmaceutical Marketing Campaigns in Full Swing; Ambulatory Antibiotic Reduction: Take the Good with the Bad; Nefazodone Under Attack Once Again; Lindane Receives Black Box Warning; Aspirin Could Help Reduce Colorectal Adenomas
-
-
-
The recognition of non-accidental injury is critical for a pediatric
trauma patient. In the year 2000, almost 3 million reports of child
abuse were made to social service agencies. Forty-four percent of the
fatalities were children younger than 1 year of age. Not only are these
statistics alarming, but they point out the need for emergency
department and trauma physicians and nurses to recognize non-accidental
injury and aggressively protect the children who seek our medical
expertise and protection.
-
-
The final version of the recently proposed changes to the Emergency Medical Treatment and Labor Act (EMTALA) takes effect on Nov. 10. To provide you with critical information on the updated regulations from the Centers for Medicare and Medicaid Services, Thomson American Health Consultants offers "New EMTALA Regulations: Are They Too Good to be True?" an audio conference on Tuesday, Oct. 21, from 2:30-3:30 p.m., EST.
-
Pneumococcal Vaccine Ineffective at CAP Prevention; Flu Vaccine Limits
Hospitalization; Verapamil Not Up To Competition; International
Companies Unite Against SARS; New FDA Comissioner Brings Controversy;
Janssen: Dear Doctor Letter for Risperidone
-
